Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clin |
RCV001753746 | SCV001994841 | likely pathogenic | Mitochondrial disease | 2021-05-06 | reviewed by expert panel | curation | The c.3609_3612dup (p.Gly1205AsnfsTer13) variant in POLG was not in any databases (PM2). This variant results in a frameshift causing a loss of function (PVS1). There are no publications of cases with this variant. In summary, this variant meets criteria to be classified as likely pathogenic for mitochondrial disease inherited in an autosomal recessive manner. ntDNA ACMG/AMP criteria for POLG applied: PVS1, PM2 |
Eurofins Ntd Llc |
RCV000345512 | SCV000339078 | pathogenic | not provided | 2016-02-08 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV003463763 | SCV004205905 | likely pathogenic | Progressive sclerosing poliodystrophy | 2023-04-29 | criteria provided, single submitter | clinical testing |